Upgrade to SI Premium - Free Trial

Eli Lilly & Co. (LLY) to Charge $2,100 Per Dose of Bebtelovimab Antibody Drug - WSJ

August 3, 2022 3:13 PM

Lilly (NYSE: LLY) to Charge List Price of $2,100 Per Dose of Bebtelovimab Antibody Drug -- WSJ

Categories

Corporate News Trader Talk

Next Articles